Bracing for Biomarkers

Premium

Biomarkers travel a long distance between their conception in a basic research lab and their eventual use as a clinical diagnostic. As chair of the clinical labs department at Memorial Sloan Kettering Cancer Center, Martin Fleisher spends a good amount of time thinking about biomarkers and the route they take to get to the clinic. GT’s Jeanene Swanson caught up with Fleisher to ask about how to spot a good biomarker, the rigors of validation, and more.

Genome Technology: What types of biomarkers are currently being used in clinical diagnostic labs?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.